Approved for SIRTURO is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adult and pediatric patients (2 years and older and weighing at least 8 kg) with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampin and isoniazid.. Bedaquiline is a diarylquinoline antimycobacterial drug [see Microbiology (12.4) ]…
Loading full data from Know Your Drugs Institute…